Neuropsychology of Cardiovascular Disease / Edition 2by Shari R. Waldstein
Pub. Date: 01/30/2015
Publisher: Taylor & Francis
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States and most westernized nations. Both CVDs and their risk factors confer substantial risk for stroke and dementia, but are also associated with more subtle changes in brain structure and function and cognitive performance prior to such devastating clinical outcomes. It
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States and most westernized nations. Both CVDs and their risk factors confer substantial risk for stroke and dementia, but are also associated with more subtle changes in brain structure and function and cognitive performance prior to such devastating clinical outcomes. It has been suggested that there exists a continuum of brain abnormalities and cognitive difficulties associated with increasingly severe manifestations of cardiovascular risk factors and diseases that precede vascular cognitive impairment and may ultimately culminate in stroke or dementia.
This second edition examines the relations of a host of behavioral and biomedical risk factors, in addition to subclinical and clinical CVDs, to brain and cognitive function. Associations with dementia and pre-dementia cognitive performance are reported, described, and discussed with a focus on underlying brain mechanisms. Future research agendas are suggested, and clinical implications are considered. The volume is a resource for professionals and students in neuropsychology, behavioral medicine, neurology, cardiology, cardiovascular and behavioral epidemiology, gerontology, geriatric medicine, nursing, adult developmental psychology,
and for other physicians and health care professionals who work with patients with, or at risk for, CVDs.
- Taylor & Francis
- Publication date:
- Edition description:
- New Edition
Table of Contents
Section I: Behavioral, Biomedical, and Psychophysiological Risk Factors. G.E. Swan, Smoking. F. Panza, Alcohol Consumption. M. Carlson, Physical Activity and Exercise. M.F. Elias, Blood Pressure and Antihypertensives. M.F. Muldoon, Lipids, Statins, and Omega 3/6 Fatty Acids. I. Brands, Metabolic Syndrome, Type II Diabetes. I. Driscoll, S.B. Resnick, Estrogen and Testosterone. J. Gunstad, Obesity. A.L. Marsland, Inflammation. M. Robbins, M.L. Elias, D. Smith, Homocysteine and Vitamins. S.L. Seliger, Renal Biomarkers , S.R. Waldstein, J.F. Thayer, Cardiovascular Reactivity. J. Pruessner, Resting and Stress-Reactive Cortisol . Section II: Cardiovascular Disease and Interventions. C.R. Wendell, S.R. Waldstein, Subclinical Vascular Disease. N. Stroobant, Clinical Cardiovascular Disease. P. Smith, J. Blumenthal, Coronary Artery Bypass Surgery. R. Cohen, Heart Failure, Heart Transplantation. Section III: Dementia and Stroke. J. Merino, V. Hachinski, Vascular Cognitive Impairment. C. Qiu, CVD Risk Factors and Dementias. C. DeCarli, S. Lockhart, Structural Brain Mechanisms and Dementia. J.C. de la Torre, Cerebral Perfusion and Dementia. D. Libon, Vascular Dementia and Stroke.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >